Get started Log in

HAE — Haemonetics Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Market Cap
$5.52bn
Enterprise Value
$6.47bn
Revenue
$1.33bn

Brief: Haemonetics Earns CE Mark For Vascade® Vascular Closure Product Portfolio
12/09/2022 11:45
Brief: Haemonetics Announces Agreement To Offer Enhanced Transfusion Management Software To Epic's Global Network Of Hospitals
29/08/2022 21:12
U.S. RESEARCH ROUNDUP-Isoplexis, Seer, Wesco International
11/08/2022 08:38
Haemonetics Corp reports results for the quarter ended in June - Earnings Summary
10/08/2022 12:38
Brief: Haemonetics reports Q1 2023 results
10/08/2022 11:12
Haemonetics Corp expected to post earnings of 51 cents a share - Earnings Preview
08/08/2022 11:02
NYSE ORDER IMBALANCE 53681.0 SHARES ON BUY SIDE
24/06/2022 20:50
Haemonetics Corp reports results for the quarter ended in March - Earnings Summary
10/05/2022 12:43
Brief: Haemonetics Corp - QTRLY Revenue $265 Million, Up 18%
10/05/2022 12:16
Haemonetics Corp expected to post earnings of 60 cents a share - Earnings Preview
06/05/2022 11:02
Brief: Haemonetics Appoints James D'Arecca As Chief Financial Officer
21/03/2022 20:36
NYSE ORDER IMBALANCE 60175.0 SHARES ON BUY SIDE
18/03/2022 19:51
Citi says Omicron blow to plasma collection to weigh on CSL's FY23 earnings
09/02/2022 19:57
U.S. RESEARCH ROUNDUP-Karyopharm Therapeutics, Thomson Reuters, Transdigm Group
09/02/2022 07:41
Haemonetics Corp reports results for the quarter ended in December - Earnings Summary
08/02/2022 13:43
Brief: Haemonetics Q3 Earnings Per Share $0.45
08/02/2022 12:01
Haemonetics Corp expected to post earnings of 73 cents a share - Earnings Preview
04/02/2022 12:13
Haemonetics Corp reports results for the quarter ended in September - Earnings Summary
09/11/2021 12:02
NYSE ORDER IMBALANCE 53677.0 SHARES ON SELL SIDE
15/10/2021 20:50
NYSE ORDER IMBALANCE 80503.0 SHARES ON SELL SIDE
11/10/2021 20:50